Results 141 to 150 of about 8,348 (154)

SYNTHESIS OF RALTEGRAVIR

2013
GURJAR MUKUND KESHAV, SONAWANE SWAPNIL PANDITRAO, MAIKAP GOLAKCHANDRA SUDARSHAN, PATIL GULABRAO DAGADU, SHINDE SHIVNATH BHAUPATIL, PATIL PANKAJ SHALIKRAO, MEHTA SAMIT SATISH   +6 more
openaire   +7 more sources

Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation

Journal of Clinical Pharmacology, 2011
Julie Stone, Marian Iwamoto
exaly  

Raltegravir

Reactions Weekly
openaire   +1 more source

Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor

Journal of Clinical Pharmacology, 2011
Marian Iwamoto
exaly  

Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

Journal of Clinical Pharmacology, 2008
Julie Stone, Larissa A Wenning
exaly  

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Lancet, The, 2007
JOSÉ M Gatell, Adriano Lazzarin, BEATRIZ Grinsztejn   +2 more
exaly  

Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

Journal of Antimicrobial Chemotherapy, 2017
Carmen de Mendoza, Vicente Soriano, Ana Trevino   +2 more
exaly  

Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies

Expert Opinion on Drug Metabolism and Toxicology, 2010
David Bürger
exaly  

New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors

Journal of Antimicrobial Chemotherapy, 2014
Isabelle Malet, Stefano Alcaro, Anna Artese   +2 more
exaly  

Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc

Antiviral Research, 2010
Darius Armstrong-James, Justin Stebbing, Mark Nelson   +2 more
exaly